Utah Medical Products (Utah Medical Products) LT-Debt-to-Total-Asset : 0.00 (As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Utah Medical Products LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Utah Medical Products's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.00.

Utah Medical Products's long-term debt to total assets ratio declined from Mar. 2023 (0.00) to Mar. 2024 (0.00). It may suggest that Utah Medical Products is progressively becoming less dependent on debt to grow their business.

Utah Medical Products LT-Debt-to-Total-Asset Historical Data

The historical data trend for Utah Medical Products's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Utah Medical Products LT-Debt-to-Total-Asset Chart

Utah Medical Products Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

Utah Medical Products Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Utah Medical Products LT-Debt-to-Total-Asset Calculation

Utah Medical Products's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0.295	/	135.458
	=	0.00

Utah Medical Products's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	0.285	/	135.441
	=	0.00

Utah Medical Products (NAS:UTMD) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Utah Medical Products LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Utah Medical Products's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Utah Medical Products (Utah Medical Products) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Utah Medical Products Inc (NAS:UTMD) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

UTM:Germany

Address

7043 South 300 West, Midvale, UT, USA, 84047

Website

http://www.utahmed.com

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices.

Executives

Paul O Richins	director, officer: VP, Treasurer, Asst. Secretary	7043 SOUTH 300 WEST, MIDVALE UT 84047
Barbara A Payne	director
Ernst G Hoyer	director
Kevin L Cornwell	director, officer: Chairman, CEO, Secretary
Brian Koopman	officer: Principal Financial Officer	108 E 1700 S, BOUNTIFUL UT 84010
James H Beeson	director	7043 SOUTH 300 WEST, MIDVALE UT 84047
Greg A Leclaire	officer: Chief Financial Officer	5225 WILEY POST WAY, SUITE 500, SALT LAKE CITY UT 84116
Stephen W Bennett	director